These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24947545)

  • 1. The recent progresses on the improved therapy of melanoma by novel drug delivery systems.
    Taymouri S; Varshosaz J
    Curr Drug Targets; 2014; 15(9):829-42. PubMed ID: 24947545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Progresses of Functional Nanomaterials for Imaging Diagnosis and Treatment of Melanoma.
    Zhu C; Zhu Y; Pan H; Chen Z; Zhu Q
    Curr Top Med Chem; 2019; 19(27):2494-2506. PubMed ID: 31642783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
    Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
    Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress on hydrogel-based drug therapy in melanoma immunotherapy.
    He W; Zhang Y; Qu Y; Liu M; Li G; Pan L; Xu X; Shi G; Hao Q; Liu F; Gao Y
    BMB Rep; 2024 Feb; 57(2):71-78. PubMed ID: 38053295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future developments in the selectivity of anticancer agents: drug delivery and molecular target strategies.
    Mayer LD
    Cancer Metastasis Rev; 1998 Jun; 17(2):211-8. PubMed ID: 9770118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
    Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of drugs and plasmid DNA for cancer therapy.
    Teo PY; Cheng W; Hedrick JL; Yang YY
    Adv Drug Deliv Rev; 2016 Mar; 98():41-63. PubMed ID: 26529199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery to tumours: recent strategies.
    Reddy LH
    J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
    Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
    Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
    Sasse AD; Sasse EC; Clark LG; Ulloa L; Clark OA
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005413. PubMed ID: 17253556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in nanomedicine for melanoma treatment.
    Tang JQ; Hou XY; Yang CS; Li YX; Xin Y; Guo WW; Wei ZP; Liu YQ; Jiang G
    Int J Cancer; 2017 Aug; 141(4):646-653. PubMed ID: 28340496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review.
    Hani U; Osmani RA; Bhosale RR; Shivakumar HG; Kulkarni PK
    Curr Drug Targets; 2016; 17(3):337-52. PubMed ID: 25944014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for gene therapy and lymphokine therapy for metastatic melanoma.
    Sivanandham M; Scoggin SD; Sperry RG; Wallack MK
    Ann Plast Surg; 1992 Jan; 28(1):114-8. PubMed ID: 1642399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.